Abstract
Tumor necrosis factor (TNF) inhibitor therapy for infammatory bowel disease (IBD) has been associated with an increased risk of rheumatoid arthritis and other infammatory conditions. Our retrospective study did not show an increased risk when compared with non-anti-TNF therapy for IBD.
Author supplied keywords
Cite
CITATION STYLE
APA
Keluth Chavan, A., Jha, P., Perez, J. A., Harper, E., Sinh, P., Cooper, G., … Mansoor, E. (2025). Risk of Paradoxical Rheumatoid Arthritis in Inflammatory Bowel Disease Patients Exposed to Tumor Necrosis Factor Inhibitors: A Propensity-Matched Multicenter Study. Inflammatory Bowel Diseases, 31(4), 1168–1173. https://doi.org/10.1093/ibd/izae203
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free